Although Asian thyroid practices have implemented the American Thyroid Association guidelines, significant deviations in actual risk of malignancy (ROM) have been reported. With review of the literature from Asia, the authors examine the underlining reasons for actual ROMs reported in Asia being so different from western practice based on the author's perspective. Although the most popular diagnostic system for thyroid cytology used in Asian countries is the Bethesda system, the Japan Thyroid Association published clinical guidelines, including a national reporting system for thyroid cytology, to adapt conservative clinical management (active surveillance and strict triage patients for surgery) for low-risk thyroid carcinomas. As less aggressive clinical management is favoured in Asian societies, strict triage of patients with indeterminate thyroid nodules for surgery is usually applied, which ultimately reduces overtreatment of indolent thyroid tumours. As a result, low resection rates and high ROMs for indeterminate nodules were achieved in Asian practices using the same Bethesda system. Recently, borderline thyroid tumours were introduced in the thyroid tumour classification and significant decreases in ROMs have been reported in the indeterminate categories in western practice.
preoperative FNA, 4, 5 which poses difficulties for management. Thus, many authors and clinical guidelines have devoted much attention to how to handle patients with cytologically indeterminate thyroid nodules. [1] [2] [3] [4] [5] The American National Institutes of Health system for reporting thyroid FNAC (Bethesda system) aimed to improve diagnosis of indeterminate thyroid nodules. Its strategies include: (1) more precise and defined standardised nomenclature and morphological criteria; (2) the indeterminate category was divided into lower-risk (AUS/FLUS); intermediate-risk (FN/SFN) and higher-risk (SM); (3) risks of malignancy (ROMs) were estimated in each cytological category to serve as a quality control guide; (4) the target number of AUS/FLUS was set at less than 7% to minimise its overuse; and (5) clinical management of cytological categories were defined for improved communication among patients, cytopathologists and clinical doctors. 4, 5 Many reports have confirmed its high overall accuracy, and concluded that the Bethesda system was reliable and valid. [6] [7] [8] [9] [10] [11] [12] However, there are unforeseen consequences for thyroid cancer treatment that were not appreciated prior to
2009, when the first edition of Bethesda system and the 2009
Revised American Thyroid Association (ATA) management guidelines for patients with thyroid nodules and differential thyroid cancers were published. Overdiagnosis and overtreatment of indolent thyroid cancers has been highlighted by epidemiologists, 13, 14 and further confirmed by Korean experience, 15 in which the ATA thyroid cancer management guidelines and the Bethesda system were implicated.
In this opinion paper, the authors introduce Asian practices for patients with thyroid nodules and describe Asian clinical practice (active surveillance for indeterminate thyroid nodules and low-risk thyroid carcinomas), as reliable and valid means for reducing overdiagnosis and overtreatment of borderline thyroid tumours and low-risk thyroid carcinomas. 16, 17 In addition, there are reports of significant variations in ROM in cytological-histological correlation studies even when the ATA thyroid cancer management guidelines and the Bethesda system were employed. 6, [9] [10] [11] [18] [19] [20] [21] [22] This article presents high quality data provided by members of the Working Group of Asian Thyroid FNA Cytology, [22] [23] [24] [25] [26] [27] [28] [29] which confirms high ROMs in the indeterminate FNA categories and low rates of non-invasive follicular neoplasm with papillary-like nuclear features (NIFTP) in most Asian thyroid FNA practice. 20, 22, 30 This article also provides an overview of Asian thyroid FNAC practice and gives possible reasons for the significant differences between Asian and western practice.
| REVIE W OF REPORTS BY MEMBERS OF THE WORKING GROUP OF ASIAN THYROID FNAC IN ENGLISH

| China
Zhu et al published their thyroid FNA practice in 2015. 31 They used haematoxylin-eosin staining and the five-tiered British system for diagnosis. Resection rates (RRs) were low at 41.6% in Thy 3, and
ROMs were high in Thy 3 (51.9%) and Thy 4 (92.9%). Zhu et al further applied subclassification to the Thy 3 category, dividing it into four subcategories: Thy 3-PTC (papillary thyroid carcinoma), Thy They conducted an extensive literature search of reports published from India on thyroid FNAC and found 28 out of 50 studies that met the inclusion criteria for their meta-analysis. 29 Most thyroid aspiration samples were collected by pathologists using manual palpation, and the Bethesda system is the most widely used reporting system in India. This meta-analysis revealed that ROMs (average and 95% confidence interval) for the six Bethesda categories were 15% (6%-24%) for non-diagnostic, 3% (2%-4%) for benign, 34% (23%-45%) for AUS/FLUS, 26% (15%-36%) for FN/SFN, 69% (55%-84%)
for SM and 94% (89%-98%) for malignant. 29 The Bongiovanni et al. 9 The current authors speculate that most Asian cytopathologists, who are practicing in populations with a high prevalence of PTC, may employ stricter diagnostic criteria for PTCtype nuclear features. As significant observer variability in evaluation of PTC-type nuclear features in histological diagnosis of encapsulated follicular pattern tumours was reported between American and Japanese pathologists, 40 and between American and Korean pathologists, 41 differences may also occur in cytological diagnosis between western and Asian pathologists. This is one hypothesis as to why (Table 3) . [53] [54] [55] [56] [57] This hypothesis was further supported by recent NIFTP studies that report that in some geographic areas of the world 10%-30% of newly diagnosed thyroid carcinomas could be re-designated as NIFTP, and significant numbers of NIFTPs were classified in the indeterminate cytological categories. [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] However, the improved prognosis of thyroid carcinomas in indeterminate cytological categories reported in western practice was not confirmed in a study from Asia. In the study by Sugino et al, Kobe, Japan. 22 The cytological-histological correlation study, including biopsies for non-surgical cases, such as undifferentiated carcinomas and malignant lymphomas, is summarised in Table 4 
FT-UMP (3) FTC (6) 20. 44 Borderline tumours were rarely found:
4.7% of malignancy over 5 years in Kuma Hospital (Table 4) . However, rescue surgery was performed more for borderline tumours (21.0% of malignancies) during active surveillance ( 78 and by Kovatch et al 79 in western practice to reflect better risk stratification of thyroid cancer, which is a common practice in Asia. 16, 17, 22, 24, 42, 43, 46 Of the proposed modifications and updates for the second edition of the Bethesda system, application of molecular tests, clinicoradiological risk stratification, and a multidisciplinary team approach for both AUS/FLUS and FN/SFN nodules were emphasised. 80 This looks like the active surveillance recommended by the JTA clinical guidelines, which is common practice in Asia and Japan. 
| CONCLUSION
